8-K - Apellis Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On January 12, 2026, Apellis Pharmaceuticals, Inc. (the “Company”) issued a press release announcing preliminary

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 12, 2026 104 Cover Page Interactive Data File (embedded

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1